Press Releases Year All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights Aug 17, 2026 Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update Aug 05, 2026 Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026 Jul 22, 2026 Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi) Jun 23, 2026 Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026 Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 May 04, 2026 Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update Mar 09, 2026 Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Mar 02, 2026 Coherus Oncology to Participate in Upcoming Investor Conferences Feb 23, 2026 Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock Feb 17, 2026
Year All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights Aug 17, 2026 Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update Aug 05, 2026 Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026 Jul 22, 2026 Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi) Jun 23, 2026 Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026 Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 May 04, 2026 Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update Mar 09, 2026 Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Mar 02, 2026 Coherus Oncology to Participate in Upcoming Investor Conferences Feb 23, 2026 Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock Feb 17, 2026
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update Aug 05, 2026
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi) Jun 23, 2026
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update Mar 09, 2026
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Mar 02, 2026
